First Financial Equity Corporation’s iShares Biotechnology ETF IBB Stock Holding History

First Financial Equity Corporation’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$515K	Buy	+5,277	New	+$505K	0.09%	209

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

First Financial Equity Corporation's IBB Position: Q1 2017 in Review

First Financial Equity Corporation opened a new position in iShares Biotechnology ETF (IBB) in Q1 2017: 5,277 shares worth $515K. The stake represents 0.09% of the portfolio and ranks #209 among its holdings.

520 funds tracked by Wall St. Rank hold IBB as of Q1 2017.

First Financial Equity Corporation held 5,277 shares of iShares Biotechnology ETF worth $515K as of Q1 2017.
iShares Biotechnology ETF was a new First Financial Equity Corporation position in Q1 2017.
iShares Biotechnology ETF made up 0.09% of First Financial Equity Corporation's portfolio in Q1 2017, its #209 holding.
520 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2017.

Based on First Financial Equity Corporation's 13F filing for Q1 2017, filed 16 May 2017.